Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Scientific Reports
|
March 31, 2026
Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients
Bern-Thomas Nyang'wa, Ilaria Motta, Ronelle Moodliar, et al.
The Journal of Antimicrobial Chemotherapy
|
March 28, 2018
Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation
James Millard, Henry Pertinez, Laura Bonnett, et al.
The Journal of Antimicrobial Chemotherapy
|
April 25, 2022
Population pharmacokinetics of ethambutol in African children: a pooled analysis
Tjokosela Tikiso, Helen McIlleron, Mahmoud Tareq Abdelwahab, et al.
BMC Infectious Diseases
|
August 29, 2016
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
Meredith Milstein, Leonid Lecca, Charles Peloquin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials
Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Pharmaceutics
|
December 23, 2022
Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberculosis</i> Infection
Laura Sibley, Andrew D White, Charlotte Sarfas, et al.
Thorax
|
May 2, 2020
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay
Wilber Sabiiti, Khalide Azam, Eoghan Charles William Farmer, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Scientific Reports
|
March 31, 2026
Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients
Bern-Thomas Nyang'wa, Ilaria Motta, Ronelle Moodliar, et al.
The Journal of Antimicrobial Chemotherapy
|
March 28, 2018
Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation
James Millard, Henry Pertinez, Laura Bonnett, et al.
The Journal of Antimicrobial Chemotherapy
|
April 25, 2022
Population pharmacokinetics of ethambutol in African children: a pooled analysis
Tjokosela Tikiso, Helen McIlleron, Mahmoud Tareq Abdelwahab, et al.
BMC Infectious Diseases
|
August 29, 2016
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
Meredith Milstein, Leonid Lecca, Charles Peloquin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials
Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Pharmaceutics
|
December 23, 2022
Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberculosis</i> Infection
Laura Sibley, Andrew D White, Charlotte Sarfas, et al.
Thorax
|
May 2, 2020
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay
Wilber Sabiiti, Khalide Azam, Eoghan Charles William Farmer, et al.
Page
of 4